Sign In
Buy LIVN
$80.14
-0.91 (-1.12%)
At Close: Jul 31, 2026
LONDON--(BUSINESS WIRE)---- $LIVN #epilepsy--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (A
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
09:00am, Tuesday, 02'nd Dec 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Ob
LivaNova PLC $LIVN Shares Sold by Envestnet Asset Management Inc.
04:24am, Wednesday, 26'th Nov 2025
Envestnet Asset Management Inc. trimmed its stake in shares of LivaNova PLC (NASDAQ: LIVN) by 78.4% in the second quarter, according to the company in its most recent 13F filing with the Securities an
LivaNova to Present at Piper Sandler Healthcare Conference in December
09:00am, Tuesday, 25'th Nov 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general
LONDON--(BUSINESS WIRE)---- $LIVN #epilepsy--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) assi
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
03:26pm, Wednesday, 12'th Nov 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap a
LivaNova PLC (LIVN) Q3 2025 Earnings Call Transcript
03:41pm, Wednesday, 05'th Nov 2025
LivaNova PLC ( LIVN ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Vladimir Makatsaria - CEO & Director Alex Shvartsburg - Chief Financial Officer Ahmet Tezel - Chief Innova
LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates
08:11am, Wednesday, 05'th Nov 2025
LivaNova (LIVN) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.9 per share a year ago.
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
06:00am, Wednesday, 05'th Nov 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2025 and raised full-
Is LivaNova (LIVN) Stock Undervalued Right Now?
11:36am, Friday, 31'st Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
LivaNova to Present at Wolfe Research Healthcare Conference in November
09:00am, Thursday, 23'rd Oct 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsbur
LivaNova PLC $LIVN Shares Sold by Yousif Capital Management LLC
04:38am, Thursday, 23'rd Oct 2025
Yousif Capital Management LLC cut its holdings in shares of LivaNova PLC (NASDAQ: LIVN) by 2.3% during the second quarter, according to the company in its most recent filing with the Securities and Ex
LivaNova: Robust Fundamentals, Long-Term Growth Potential
11:50pm, Wednesday, 22'nd Oct 2025
LivaNova remains a 'BUY' with a raised price target of $61/share, reflecting strong recent results and long-term growth potential. LIVN delivered double-digit revenue growth, improved margins, and rai
LivaNova to Announce Third-Quarter 2025 Results
09:00am, Wednesday, 08'th Oct 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5,
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
09:00am, Tuesday, 07'th Oct 2025
LONDON--(BUSINESS WIRE)---- $LIVN #livn--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the International Surgical Sleep Society (ISSS)
